Ablation of Cullin-5 in Primary Human T Cells Improves Tumor Killing and Persistence in BCMA-Targeting CAR-T Cells in a Multiple Myeloma Model

被引：1
|
作者：
Bachl, Stefanie [1 ,2 ]
Talbot, Alexis [1 ,2 ]
Ching, Carter [1 ,2 ]
Kale, Nupura [1 ,2 ]
Li, Zhongmei [2 ]
Diolaiti, Morgan [3 ]
Chen, Amy Peixin [1 ,2 ]
Muldoon, Joseph [1 ,2 ]
Liu, Chang [1 ,2 ]
Martin, Thomas [1 ,3 ]
Eyquem, Justin [1 ,2 ,3 ,4 ,5 ]
Carnevale, Julia [1 ,2 ,5 ]
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Gladstone UCSF Inst Genom Immunol, San Francisco, CA USA
[3] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[4] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94143 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182565
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cilta-cel, a BCMA-targeting CAR-T therapy for patients with multiple myeloma
    Jagannath, Sundar
    Jackson, Carolyn C.
    Schecter, Jordan M.
    Lendvai, Nikoletta
    Sun, Huabin
    Akram, Muhammad
    Patel, Nitin
    Martin, Thomas G.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (05) : 339 - 350
  • [2] Phase II Study of Fully Human BCMA-Targeting CAR-T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/ Refractory Multiple Myeloma
    Chen, Wenming
    Fu, Chengcheng
    Fang, Baijun
    Liang, Aibin
    Xia, Zhongjun
    He, Yanjuan
    Lu, Jin
    Liu, Hui
    Hou, Ming
    Cai, Zhen
    Yang, Wei
    Hao, Siguo
    Jiang, Songfu
    Jing, Hongmei
    Liu, Jing
    Du, Xin
    Fu, Rong
    Mei, Heng
    Zhu, Zunmin
    Yang, Yanli
    Liu, Hong
    Yuan, Daijing
    Zhao, Hongxia
    Xiao, Jun
    Wang, Wei
    Wang, Huamao
    Li, Zonghai
    [J]. BLOOD, 2022, 140 : 4564 - 4565
  • [3] Apheresis Products from Patients with Multiple Myeloma Treated with G-CSF Are a Suitable Source of T Cells for the Production of BCMA-Targeting CAR-T Cells
    Battram, Anthony M.
    Oliver-Caldes, Aina
    Bosch i Crespo, Miquel
    Suarez-Lledo, Maria
    Lozano, Miquel
    Martinez-Cibrian, Nuria
    Cid, Joan
    Moreno, David F.
    Gerardo Rodriguez-Lobato, Luis
    Urbano-Ispizua, Alvaro
    Fernandez de Larrea, Carlos
    [J]. BLOOD, 2021, 138
  • [4] A BCL2L1 armoured BCMA-targeting CAR T cells to overcome exhaustion and enhance persistence in multiple myeloma
    Maity, Ranjan
    Benaoudia, Sacha
    Lee, Holly
    Barakat, Elie
    Leblay, Noemie
    Ahn, Sungwoo
    Zemp, Franz
    Mahoney, Douglas
    Neri, Paola
    Bahlis, Nizar
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S12 - S12
  • [5] CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
    Davenport, Alexander J.
    Jenkins, Misty R.
    Cross, Ryan S.
    Yong, Carmen S.
    Prince, H. Miles
    Ritchie, David S.
    Trapani, Joseph A.
    Kershaw, Michael H.
    Darcy, Phillip K.
    Neeson, Paul J.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2015, 3 (05) : 483 - 494
  • [6] Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma
    Martin, Thomas G.
    Madduri, Deepu
    Pacaud, Lida
    Usmani, Saad Z.
    [J]. FUTURE ONCOLOGY, 2023, 19 (34) : 2297 - 2311
  • [7] Genetic Disruption of Blimp-1 Drastically Augments the Persistence and Anti-Tumour Efficacy of BCMA-Targeting CAR-T Cells
    Battram, Anthony M.
    Oliver-Caldes, Aina
    Bosch i Crespo, Miquel
    Cardus, Oriol
    Moreno, David F.
    Gerardo Rodriguez-Lobato, Luis
    Urbano-Ispizua, Alvaro
    Fernandez de Larrea, Carlos
    [J]. BLOOD, 2022, 140 : 2360 - 2361
  • [8] Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma
    Wachsmann, Tassilo L. A.
    Meeuwsen, Miranda H.
    Remst, Dennis F. G.
    Buchner, Karen
    Wouters, Anne K.
    Hagedoorn, Renate S.
    Falkenburg, J. H. Frederik
    Heemskerk, Mirjam H. M.
    [J]. BLOOD ADVANCES, 2023, 7 (20) : 6178 - 6183
  • [9] Cite-Seq Profiling of T Cells in Multiple Myeloma Patients Undergoing BCMA Targeting CAR-T or Bites Immunotherapy
    Leblay, Noemie
    Maity, Ranjan
    Barakat, Elie
    McCulloch, Sylvia
    Duggan, Peter
    Jimenez-Zepeda, Victor
    Bahlis, Nizar J.
    Neri, Paola
    [J]. BLOOD, 2020, 136
  • [10] BCMA CAR-T cells in multiple myeloma-ready for take-off?
    Scheller, Lukas
    Tebuka, Erius
    Rambau, Peter Fabian
    Einsele, Hermann
    Hudecek, Michael
    Prommersberger, Sabrina Rebecca
    Danhof, Sophia
    [J]. LEUKEMIA & LYMPHOMA, 2024, 65 (02) : 143 - 157
12345